Show simple item record

dc.creatorStepanović-Petrović, Radica
dc.date.accessioned2019-09-02T11:22:50Z
dc.date.available2019-09-02T11:22:50Z
dc.date.issued2010
dc.identifier.issn0004-1963
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/1447
dc.description.abstractHormonal contraception is the most effective method of fertility control, with possible major and minor side-effects, especially for certain groups of women. The most serious side effects are thromboembolic events. That is why, it should not be prescribed in women aged over 35 years who smoke and have the other cardiovascular risks. In some cases hormonal replacement therapy (HRT) has no alternative with similar effects. But HRT also has risks for venous thromboembolism and breast cancer. So, when there is clear indication for HRT it is necessary to use minimum effective dose of the drug for the shortest period, in order to minimize therapy risks. The patient should be informed about all risks of HRT therapy.en
dc.description.abstractHormonska kontracepcija (HK) je najefikasniji metod kontrole začeća, ali može biti praćena manjim ili većim neželjenim efektima, posebno u izvesnim rizičnim grupama. Najozbiljniji neželjeni efekti jesu tromboembolijski poremećaji. Zbog toga se HK ne preporučuje ženama iznad 35 godina koje puše ili imaju druge faktore rizika za kardiovaskularna oboljenja. U nekim slučajevima hormonska supstituciona terapija (HST) nema alternativu sa sličnim efektima. Ali i ovi lekovi nose rizik od nastanka tromboze i kancera dojke. Zato, kada postoji jasna indikacija za primenu HST neophodno je primeniti najnižu efikasnu dozu hormona u toku najkraćeg perioda, kako bi se rizici sveli na najmanju moguću meru. Žene treba da budu potpuno informisane o rizicima primene ove terapije.sr
dc.publisherSavez farmaceutskih udruženja Srbije, Beograd
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-sa/4.0/
dc.sourceArhiv za farmaciju
dc.subjectbenefits/risks of hormonal contraceptionen
dc.subjectbenefits/risks of hormonal replacement therapyen
dc.subjectkoristi/rizici hormonske kontracepcijesr
dc.subjectkoristi/rizici hormonske supstitucione terapijesr
dc.titleHormonska kontracepcija i hormonska supstituciona terapijasr
dc.typearticle
dc.rights.licenseBY-SA
dcterms.abstractСтепановић-Петровић, Радица; Хормонска контрацепција и хормонска супституциона терапија; Хормонска контрацепција и хормонска супституциона терапија;
dc.citation.volume60
dc.citation.issue2
dc.citation.spage158
dc.citation.epage167
dc.citation.other60(2): 158-167
dc.citation.rankM52
dc.identifier.scopus2-s2.0-77954191656
dc.identifier.fulltexthttps://farfar.pharmacy.bg.ac.rs//bitstream/id/345/1445.pdf
dc.identifier.rcubconv_421
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record